Pimavanserin for patients with Alzheimer's disease psychosis

被引：9
|
作者：
Schneider, Lon S. [1 ,2 ]
机构：
[1] Univ Southern Calif, Dept Psychiat & Behav Sci, Keck Sch Med, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Dept Neurol, Keck Sch Med, Los Angeles, CA 90033 USA
来源：
LANCET NEUROLOGY | 2018年 / 17卷 / 03期
关键词：
PLACEBO; DEMENTIAS; EFFICACY;
D O I：
10.1016/S1474-4422(18)30052-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：194 / 195
页数：2
相关论文
共 50 条
  • [41] An Open-Label Extension Study To Determine the Safety of Pimavanserin in Patients with Parkinson's Disease and Psychosis
    Mills, Roger
    Johnson, Ann D.
    Williams, Hilde
    Bahr, Daun
    Revell, Stephen
    NEUROLOGY, 2009, 72 (11) : A319 - A319
  • [42] Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
    Cummings, Jeffrey
    Isaacson, Stuart
    Mills, Roger
    Williams, Hilde
    Chi-Burris, Kathy
    Corbett, Anne
    Dhall, Rohit
    Ballard, Clive
    LANCET, 2014, 383 (9916): : 533 - 540
  • [43] Motor-Related and Cognition-Related Safety of Pimavanserin in Patients with Parkinson's Disease Psychosis
    不详
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 : S191 - S192
  • [44] An open-label extension study to determine the safety of pimavanserin in patients with Parkinson's disease and psychosis
    Mills, R.
    Johnson, A. D.
    Bahr, D.
    Williams, H.
    Revell, S.
    MOVEMENT DISORDERS, 2009, 24 : S268 - S269
  • [45] Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole
    Madhusoodanan, Subramanian
    Shah, Payal
    CLINICAL INTERVENTIONS IN AGING, 2008, 3 (03): : 491 - 501
  • [46] Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease
    Mintzer, JE
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 23 - 25
  • [47] Motor-Related and Cognition-Related Safety of Pimavanserin in Patients with Parkinson's Disease Psychosis
    Espay, A.
    Abler, V.
    Ballard, C.
    Berrio, A.
    Coate, B.
    Brain, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 70 : S191 - S192
  • [48] Clinical Experience in Over 100 Using Pimavanserin for Parkinson's Disease Psychosis
    Gupta, Harsh
    Lyons, Kelly
    Pahwa, Rajesh
    NEUROLOGY, 2019, 92 (15)
  • [49] Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial
    Weintraub, Daniel
    Espay, Alberto J.
    Sharma, Vibhash D.
    Tariot, Pierre N.
    Abler, Victor
    Pathak, Sanjeev
    Stankovic, Srdjan
    PARKINSONISM & RELATED DISORDERS, 2024, 119
  • [50] Mortality in Patients with Parkinson Disease Psychosis Receiving Pimavanserin and Quetiapine: A Retrospective Review
    Longardner, Katherine
    Wright, Brenton
    Alakkas, Aljoharah
    Nahab, Fatta B.
    ANNALS OF NEUROLOGY, 2020, 88 : S193 - S193
12345